Wei Zhu

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Brandon W. Higgs, Zheng Liu, Barbara White et al. · Annals of the Rheumatic Diseases · 2011 · 408 citations

Life Sciences, Immunology, Molecular Medicine +17

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases

David J. Wong, Bory Kea, Rob Pesich et al. · PLoS ONE · 2012 · 194 citations · Full text

Medicine, Dermatology, Immunology +17

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients

Brandon W. Higgs, Wei Zhu, Chris Morehouse et al. · Annals of the Rheumatic Diseases · 2013 · 166 citations · Full text

Life Sciences, Immunology, Pharmacology +13

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

Katie Streicher, Wei Zhu, Kim Lehmann et al. · Oncogene · 2011 · 133 citations

Medicine, Molecular Biology, Oncology +17

A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4⁺T cell receptor repertoire clonality

Wei Zhu, Claire Germain, Zheng Liu et al. · OncoImmunology · 2015 · 112 citations · Full text

Life Sciences, Immunology, Oncology +17